Special Drug Use-results Surveillance of Scemblix Tablets
NCT05421091
·
clinicaltrials.gov ↗
COMPLETED
Status
550
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Myeloid Leukemia
Interventions
OTHER:
Asciminib
Sponsor
Novartis Pharmaceuticals